11 - 16 of 16 Results
ORNL will develop an advanced high-performing RTG using a novel radioisotope heat source.
Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.
The vast majority of energy conversion technologies and industrial processes depend on heat exchangers for transferring heat between fluids.
An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence